Trial intelligence / Profile preview

NuCel with Collagen Matrix for Wound Healing

NCT02314416Phase 4Withdrawn

Sponsor
Augusta University
Start
May 2015
Primary completion
May 2015
Modality
Adult Stem Cells, Tissue Cells
01

Overview

Phase 4, randomised trial of NuCel in wound (2 arms), sponsored by Augusta University. Primary endpoint: Maturation of Collagen Matrix (Changes in color) at Day 28. Planned start May 2015; status: withdrawn.

02

Drugs

NuCel
03

Conditions

wound

Beyond the preview

Go deeper on NCT02314416.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02314416.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call